(Q43577777)

English

An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial

scientific article published in April 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Initio Co-ordinating Committee

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Contemporary Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

160-175

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with 500 × 106/l CD4 cells treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinica

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900123-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0197-2456(00)00123-9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43577777&oldid=2101604236"